National COVID-19 Convalescent Plasma Project National COVID-19 Convalescent Plasma Project

National COVID-19 Convalescent Plasma Project

National COVID-19 Convalescent Plasma Project

  • Health Care Providers
  • Virology
  • Uses of Plasma
  • Seeking Treatment
  • Key Scientific Papers
  • News
  • Antibodies
  • Home
  • Health Care Providers
  • Component 3: Clinical Trials

Protocols for Outpatients Infected

Consent Forms

Jaiswal - Stanford Consent Form Template

The suggested addendum addendum to standard institutional blood transfusion consent.

Protocols

Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized Double-Blind, Phase 2 Study Comparing the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma vs. Placebo in Emergency Room Patients (Jaiswal, Approved) 

Convalescent Plasma to Limit Coronavirus Associated Complications: A Randomized, Double-Blind, Controlled, Phase 2 Study Comparing the Efficacy and Safety of Human Coronavirus Immune Plasma (HCIP) vs. Control (SARS-CoV-2 non-immune) Plasma Among Outpatients with Symptomatic COVID-19 (Sullivan, Approved)

Component 3: Clinical Trials

  • Protocols for pediatrics
  • Protocol for asymptomatic contacts
  • Protocol for mild/moderate illness
  • Protocol for severe/critical illness
  • Protocols for Outpatients Infected
  • Facebook
  • Twitter
  • Contact Information
  • Site Map
  • Privacy Statement
  • Give
Michigan State University wordmark